MSB 2.17% $1.13 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-885

  1. 6,781 Posts.
    lightbulb Created with Sketch. 1469
    @Kingtup, I wouldn’t bet one of my MSB shares on what I think.

    I’ve googled; Reg has googled. See posts above.

    SI obviously knows what he is doing & whatever he’s done, it will be all for the one thing he has laser focus on & that is bringing REMESTEMCEL-L to market. That I do know!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.